Lung Transplant Becomes the First Step in Treating Man with Rare Autoimmune Disease

Wednesday, June 19, 2019 Respiratory Disease News
Email Print This Page Comment bookmark
Font : A-A+

Ajit Tolani was 15 years old when, while taking a shower, his hand began turning blue. Doctors diagnosed him with scleroderma, a rare autoimmune disease that can cause skin and other parts of the body to thicken and harden.

For many years, Ajit’s visible symptoms seemed minor. But hidden from view the scleroderma was attacking his lungs – until a series of health problems revealed that his condition had become terminal, and a journey to the United States for life-saving transplant surgery became Ajit’s only hope.

After his initial diagnosis as a teenager, Ajit’s condition didn’t seem to get worse. It just caused his fingers to enlarge slightly and sometimes turn blue in cold temperatures. He also took medication for some acid reflux. As a young man, he stayed active and built a successful career as an international tax lawyer, got married and had a daughter.

Ajit Tolani Undergoing Treatment at Cleveland Clinic

Then in 2014, when he was in his early 30s, his wife Shruti noticed a strange cough whenever Ajit would walk or run.

“Within a few months of that I started sometimes getting fevers, and sometimes, just suddenly, pneumonia,” says Ajit. The troubles continued for almost two years before the seriousness of his condition become apparent.

“In July of 2016 they told me – you’re fine, your lungs will be fine, you’ll get back to life. Then in September of 2016 they tell me – I’m sorry my friend, your game is over; you have only a few months to live.”

It was at this point that a friend connected the Tolanis with the family of Atul Mehta, MD, an Indian-born lung specialist working at Cleveland Clinic in the United States. By chance, Dr. Mehta was visiting India and agreed to meet with Ajit.

“He came to me with all his charts, X-rays and CT scans and asked for my advice,” says Dr. Mehta. “It was obvious that he was suffering with scleroderma and that his lungs were heavily affected. He was already at the end stage of pulmonary fibrosis, scarring in the lungs that makes it hard to breathe.”

Dr. Mehta recognized that Ajit’s esophagus also was affected by scleroderma, which was causing his acid reflux. As he’d regurgitate food and liquid, he’d sometimes inhale it into his lungs, causing regular bouts of pneumonia. All of that had led to pulmonary hypertension as well.

Knowing treatment options were limited elsewhere, Dr. Mehta urged Ajit and his family to travel to Cleveland Clinic as soon as possible. The Tolanis, guided by Cleveland Clinic’s Global Patient Services (GPS) team, flew to the United States in December 2016.

“The whole GPS team went out of their way in giving us immediate appointments and working out schedules,” says Ajit. “They offered us travel arrangements and accommodations. They had my oxygen cylinders ready when we landed in the U.S.”

By the time Ajit arrived at Cleveland Clinic, his condition had worsened. He was on continuous oxygen. Lung transplantation was his only remaining treatment option.

“He had some of the worst esophageal disease we have ever seen in our lung transplant program,” says Dr. Mehta.

That’s often a reason to deny transplant. If the esophagus isn’t working, reflux can damage the new lungs as well. But Ajit’s team at Cleveland Clinic had a plan.

“We take a lot of pride in offering this therapy to patients with advanced diseases,” says Cleveland Clinic lung transplant surgeon Kenneth McCurry, MD. “About 15 to 20 percent of the patients that we transplant have been declined by other transplant centers.”

While waiting for donor lungs, Ajit was placed on an artificial lung machine. During that time — about one month — he went into cardiac arrest, weakening his body even more. After that, he developed an infection, officially making him ineligible for transplant.

“I had to call his entire family,” says Dr. Mehta. “I told them that he may not make it to lung transplantation because he is septic and we had to remove him from the transplant waiting list.”

But the Tolani family would not give up hope.

“I said, ‘Let’s pray to God,’” says Shruti. “I think that’s what we have right now. Let’s pray to God.”

Three days later, Ajit’s infection disappeared, and his medical team agreed to relist him for lung transplant. One week later, Ajit had received his new lungs — but his battle was only half over.

While he was breathing on his own a few days after transplant, he was still the “sickest guy in the hospital,” says Cleveland Clinic thoracic surgeon Sudish Murthy, MD, PhD. “It's not just his lungs that were the problem. His whole body was profoundly deconditioned.”

To stop him from regurgitating stomach acid and potentially damaging his new lungs, Ajit was fed through a tube in his abdomen. He could not eat or drink by mouth for five months. Eventually, he healed from the transplant and regained enough strength for a second Laparoscopic Antireflux surgery to tighten the bottom of his esophagus and reduce acid reflux.

Today, Ajit remains close to Cleveland Clinic, together with Shruti and their daughter. He will take immunosuppression medications for life due to his lung transplant, but also to keep his scleroderma under control.

“My scleroderma has become much better because of these meds,” he says. “The flexibility in my fingers is full.”

He now stays active at the gym, doing yoga and gymnastics. He has started working again. And he can eat anything he likes, including his favorite food, chicken wings.

“His resolve before the transplant was inspiring and that resolve has been surpassed only by his resolve after the transplant to get better,” says Dr. McCurry. “He's done a spectacular job and worked quite hard.”

“I see life actually better than it was,” says Ajit. “Two years ago, I was just focusing on work. But now I focus on life. Cleveland Clinic has given me a second life.”

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store